Advertisement
Screener

The Cigna Group (CI) Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest

The Cigna Group Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest

The Cigna Group (CI) reported Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest of $331.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest · last filed 2026-02-26

  • The Cigna Group comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2024-12-31 was $112.00M, a 43.59% increase year-over-year.
  • The Cigna Group comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2024-09-30 was $86.00M, a 109.76% increase year-over-year.
  • The Cigna Group comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2024-06-30 was $81.00M, a 62.00% increase year-over-year.
  • The Cigna Group comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2024-03-31 was $65.00M, a 66.67% increase year-over-year.
  • The Cigna Group comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2025 was $331.00M, a 3.78% decline from fiscal 2024.
  • The Cigna Group comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2024 was $344.00M, a 65.38% increase from fiscal 2023.
  • The Cigna Group comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2023 was $208.00M, a 173.68% increase from fiscal 2022.
  • The Cigna Group comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2022 was $76.00M, a 111.11% increase from fiscal 2021.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 12 month
2025-12-31$331.00M
10-K · filed 2026-02-26
2024-12-31$112.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$198.00M
derived: sum of 2 quarters · filed 2026-02-26
$279.00M
derived: sum of 3 quarters · filed 2026-02-26
$344.00M
10-K · filed 2026-02-26
2024-09-30$86.00M
10-Q · filed 2024-10-31
$167.00M
derived: sum of 2 quarters · filed 2024-10-31
$232.00M
10-Q · filed 2024-10-31
$310.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$81.00M
10-Q · filed 2024-08-01
$146.00M
10-Q · filed 2024-08-01
$224.00M
derived: sum of 3 quarters · filed 2026-02-26
$265.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$65.00M
10-Q · filed 2024-05-02
$143.00M
derived: sum of 2 quarters · filed 2026-02-26
$184.00M
derived: sum of 3 quarters · filed 2026-02-26
$234.00M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$78.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$119.00M
derived: sum of 2 quarters · filed 2026-02-26
$169.00M
derived: sum of 3 quarters · filed 2026-02-26
$208.00M
10-K · filed 2026-02-26
2023-09-30$41.00M
10-Q · filed 2024-10-31
$91.00M
derived: sum of 2 quarters · filed 2024-10-31
$130.00M
10-Q · filed 2024-10-31
$159.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$50.00M
10-Q · filed 2024-08-01
$89.00M
10-Q · filed 2024-08-01
$118.00M
derived: sum of 3 quarters · filed 2025-02-27
$140.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$39.00M
10-Q · filed 2024-05-02
$68.00M
derived: sum of 2 quarters · filed 2025-02-27
$90.00M
derived: sum of 3 quarters · filed 2025-02-27
$102.00M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$29.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$51.00M
derived: sum of 2 quarters · filed 2025-02-27
$63.00M
derived: sum of 3 quarters · filed 2025-02-27
$76.00M
10-K · filed 2025-02-27
2022-09-30$22.00M
10-Q · filed 2023-11-02
$34.00M
derived: sum of 2 quarters · filed 2023-11-02
$47.00M
10-Q · filed 2023-11-02
$56.00M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$12.00M
10-Q · filed 2023-08-03
$25.00M
10-Q · filed 2023-08-03
$34.00M
derived: sum of 3 quarters · filed 2024-02-29
$47.00M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$13.00M
10-Q · filed 2023-05-05
$22.00M
derived: sum of 2 quarters · filed 2024-02-29
$35.00M
derived: sum of 3 quarters · filed 2024-02-29
$43.00M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$9.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$22.00M
derived: sum of 2 quarters · filed 2024-02-29
$30.00M
derived: sum of 3 quarters · filed 2024-02-29
$36.00M
10-K · filed 2024-02-29
2021-09-30$13.00M
10-Q · filed 2022-11-03
$21.00M
derived: sum of 2 quarters · filed 2022-11-03
$27.00M
10-Q · filed 2022-11-03
$36.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$8.00M
10-Q · filed 2022-08-04
$14.00M
10-Q · filed 2022-08-04
$23.00M
derived: sum of 3 quarters · filed 2023-02-23
$29.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$6.00M
10-Q · filed 2022-05-06
$15.00M
derived: sum of 2 quarters · filed 2023-02-23
$21.00M
derived: sum of 3 quarters · filed 2023-02-23
$25.00M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$9.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$15.00M
derived: sum of 2 quarters · filed 2023-02-23
$19.00M
derived: sum of 3 quarters · filed 2023-02-23
$23.00M
10-K · filed 2023-02-23
2020-09-30$6.00M
10-Q · filed 2021-11-04
$10.00M
derived: sum of 2 quarters · filed 2021-11-04
$14.00M
10-Q · filed 2021-11-04
$19.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$4.00M
10-Q · filed 2021-08-05
$8.00M
10-Q · filed 2021-08-05
$13.00M
derived: sum of 3 quarters · filed 2022-02-24
$17.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$4.00M
10-Q · filed 2021-05-07
$9.00M
derived: sum of 2 quarters · filed 2022-02-24
$13.00M
derived: sum of 3 quarters · filed 2022-02-24
$13.00M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$9.00M
derived: sum of 2 quarters · filed 2022-02-24
$9.00M
derived: sum of 3 quarters · filed 2022-02-24
$11.00M
10-K · filed 2022-02-24
2019-09-30$4.00M
10-Q · filed 2020-11-05
$4.00M
derived: sum of 2 quarters · filed 2020-11-05
$6.00M
10-Q · filed 2020-11-05
$13.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$0.00
10-Q · filed 2020-08-06
$2.00M
10-Q · filed 2020-08-06
$9.00M
derived: sum of 3 quarters · filed 2021-02-25
$2.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$2.00M
10-Q · filed 2020-05-07
$9.00M
derived: sum of 2 quarters · filed 2021-02-25
$2.00M
derived: sum of 3 quarters · filed 2021-02-25
-$4.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$0.00
derived: sum of 2 quarters · filed 2021-02-25
-$6.00M
derived: sum of 3 quarters · filed 2021-02-25
-$6.00M
10-K · filed 2021-02-25
2018-09-30-$7.00M
10-Q · filed 2019-10-31
-$13.00M
derived: sum of 2 quarters · filed 2019-10-31
-$13.00M
10-Q · filed 2019-10-31
2018-06-30-$6.00M
10-Q · filed 2019-08-01
-$6.00M
10-Q · filed 2019-08-01
2018-03-31$0.00
10-Q · filed 2019-05-02
2017-12-31-$8.00M
10-K · filed 2020-02-27
2016-12-31-$34.00M
10-K · filed 2019-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Elevance Health, Inc. (ELV)United States$86.364B16.90
HUMANA INC (HUM)United States$45.651B18.44
CENTENE CORP (CNC)United States$30.588B-6.22
MOLINA HEALTHCARE, INC. (MOH)United States$10.091B-1,697.50
Alignment Healthcare, Inc. (ALHC)United States$1.593B121.28
TRUPANION, INC. (TRUP)United States$0.984B
UNITEDHEALTH GROUP INC (UNH)United States$336.652B26.62